Smart dosing may help patients wake faster after anesthesia

NCT ID NCT07675850

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial compares a personalized dosing method for the sedative remimazolam to standard weight-based dosing in adults having non-cardiac surgery. The goal is to see if the personalized approach helps patients wake up faster and reduces drug buildup. Participants are randomly assigned to either dosing method, and their depth of anesthesia is monitored throughout surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

remimazolam

What this could lead to

If successful, this approach could help patients wake up faster after anesthesia and reduce drug side effects.

What could go wrong

This is a small, early-phase trial, so results may not apply to all patients or surgeries. The model may not work better than standard dosing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REMIMAZOLAM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Seoul National University Hospital

    Seoul, Jongno-gu, 03080, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••